MedPath

Bi-level Ventilatory Support during exacerbations of Cystic Fibrosis

Phase 3
Completed
Conditions
Cystic Fibrosis
Human Genetics and Inherited Disorders - Cystic fibrosis
Registration Number
ACTRN12605000437662
Lead Sponsor
SWSAHS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Acute respiratory exacerbation of Cystic Fibrosis (Fuchs et al 1994) requiring IV antibiotics and admission to hospital; aged over 17 years; FEV1 <60% predicted on admission.

Exclusion Criteria

Already using BVS or daytime respiratory failure on admission; problem pneumothoraces; recent massive haemoptysis; pregnant; sputum colonised with burkolderia cepacia; previous participation in this study; admitted for lung transplant work-up.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath